Heel pain is a problem that affects daily life activities and quality of life. Extracorporeal shock wave therapy (ESWT) is a treatment used for heel pain. However, some people do not benefit from ESWT treatment. The aim of this study is to determine the factors that affect the response to ESWT in the treatment of heel pain.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* \>18 years
* Unresponsive to conservative treatments (physical therapy, rest, exercises, anti-inflammatory medical treatment, insoles, etc.)
* Patients who have received ESWT treatment and 3-6 months have passed since ESWT
Exclusion Criteria:
* History of injection therapy including steroids after ESWT treatment
* Those taking NSAIDs in the last 2 weeks
* Those with a history of trauma or surgery to the foot or ankle
* Presence of rheumatic disease affecting the foot or ankle (e.g. spondyloarthritis, etc.)
* Malignancy
* Pregnancy
Primary outcome measure(s)
Calcaneal inclination angle — Day 1 This angle is established on a weight-bearing lateral foot radiograph between the calcaneal inclination axis (i.e., the lowest portion of the calcaneus) and the supporting horizontal surface. A cut-off point of ≤19° is used to diagnose symptomatic pes planus/flatfoot.
Ankle dorsiflexion degree — Day 1 The patient is in a prone position with the ankle on the test side away from the base and the leg extended. The therapist will stabilize the tibia. The normal range of ankle dorsiflexion is 20 degrees. Normal plantar flexion is 50 degrees.
Plantar fascia thickness — Day 1 To be measured by ultrasound; typically shows increased fascial thickness (\>4.0 mm) and a hypoechoic fascia.
Tibial/plantar nerve conduction study with electroneuromyography — Day 1 Nerve conductions show decreased amplitude of the compound muscle action potential (CMAP) of the tibial nerve stimulated at the ankle and recorded from the abductor hallucis and abductor digiti minimi. Sensory and mixed conduction studies are usually performed with centering techniques.
Trial sites (1)
Facility
City
Region
Status
Şişli Hamidiye Etfal Training and Research Hospital
Istanbul
Turkey (Türkiye)
More Sisli Hamidiye Etfal Training and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.